ORthopaedic Trauma Anemia With Conservative Versus Liberal Transfusion
ORACL
1 other identifier
interventional
161
0 countries
N/A
Brief Summary
The purpose of this study is to determine if there is a difference in outcomes between liberal transfusion (transfusing when hemoglobin drops below a set higher value number) and conservative transfusion (transfusing when hemoglobin drops below a set lower value number).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Mar 2014
Longer than P75 for phase_4
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2014
CompletedFirst Submitted
Initial submission to the registry
November 17, 2016
CompletedFirst Posted
Study publicly available on registry
November 23, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 24, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 24, 2022
CompletedResults Posted
Study results publicly available
June 29, 2023
CompletedJune 29, 2023
June 1, 2023
8.3 years
November 17, 2016
June 6, 2023
June 28, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Postoperative Wound Infection (Superficial or Deep) or Other Perioperative Infection
Deep infection is defined as the need for intravenous antibiotics and/or a return to surgery for debridement. Superficial infection is defined as clinical diagnosis of cellulitis or other superficial infection treated with oral antibiotics only.
one year
Secondary Outcomes (2)
Combined Secondary Outcomes
one year
Musculoskeletal Function Assessment
one year
Study Arms (2)
Liberal
OTHERBlood and blood products for transfusion. Transfusion will be done to keep Hgb \>7 g/dL.
Conservative
OTHERBlood and blood products for transfusion. Transfusion will be done to keep Hgb \> 5.5 g/dL.
Interventions
Randomization would not occur until the patient's Hgb dropped below 7 g/dL. If the patient is randomized to the liberal arm, they would be transfused to keep their Hgb \>7 g/dL. If the patient is randomized to the conservative arm, they would not be transfused until their Hgb drops below 5.5 g/dL. If the patient's Hgb does not drop below 7.0 g/dL, randomization will not be done.
Eligibility Criteria
You may qualify if:
- Trauma patients admitted to participating hospital with any Orthopaedic injury who have been determined to be stable by the Trauma Service (General Surgery) and are no longer within the resuscitation phase of initial treatment. This is defined as a normal urine output (greater than 0.5 ml/kg/hr) and a systolic blood pressure greater than 90 mmHg for greater than 6 hours without fluid bolus or transfusion during that time
- Age 18-50
- Hemoglobin less than 9 g/dL or expected drop below 9 g/dL with planned surgery
You may not qualify if:
- Pregnant ( urine pregnancy test will be done as standard of care)
- Prisoner
- Head injury (Glasgow Coma Scale less than 8 over 48 hours from presentation)
- Known cardiac (coronary artery disease, atrial fibrillation, stent placement, congestive heart failure), renal (acute or chronic renal insufficiency or failure, defined as having Serum Creatinine \>1.2 at time of enrollment), liver (Childs C cirrhosis) or pulmonary disease (chronic obstructive pulmonary disease, abnormal pulmonary function tests or history of poor pulmonary function from any cause including acute traumatic conditions such as ARDS)
- Unlikely to follow up in the surgeon's estimation
- Sickle Cell Anemia
- History of cancer
- Preexisting weakness, paresthesias, deformities, or other conditions which might affect functional outcome in the surgeon's opinion
- Spinal cord injury
- Patients with burns expected to require operative treatment
- COVID positive
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Indiana Universitylead
- Atlanta Medical Centercollaborator
Related Publications (2)
Mullis BH, Mullis LS, Kempton LB, Virkus W, Slaven JE, Bruggers J. Early Results of Orthopaedic Trauma and Anemia: Conservative Versus Liberal Transfusion Strategy. J Am Acad Orthop Surg. 2024 Mar 1;32(5):228-235. doi: 10.5435/JAAOS-D-23-00235. Epub 2023 Dec 27.
PMID: 38154083DERIVEDMullis BH, Mullis LS, Kempton LB, Virkus W, Slaven JE, Bruggers J. Orthopaedic Trauma and Anemia: Conservative versus Liberal Transfusion Strategy: A Prospective Randomized Study. J Orthop Trauma. 2024 Jan 1;38(1):18-24. doi: 10.1097/BOT.0000000000002696.
PMID: 38093439DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Significant loss to follow up; Significant resistance by multiple providers at each site to allow conservative treatment algorithm (as most felt liberal was standard of care); Slow enrollment; No funding
Results Point of Contact
- Title
- Dr. Brian H. Mullis
- Organization
- Indiana University School of Medicine Department of Orthopaedic Surgery
Study Officials
- PRINCIPAL INVESTIGATOR
Brian H Mullis, MD
Indiana University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 17, 2016
First Posted
November 23, 2016
Study Start
March 1, 2014
Primary Completion
June 24, 2022
Study Completion
June 24, 2022
Last Updated
June 29, 2023
Results First Posted
June 29, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share